Page last updated: 2024-10-21

acebutolol and Genetic Predisposition

acebutolol has been researched along with Genetic Predisposition in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cagliani, R1
Guerini, FR1
Fumagalli, M1
Riva, S1
Agliardi, C1
Galimberti, D1
Pozzoli, U1
Goris, A1
Dubois, B1
Fenoglio, C1
Forni, D1
Sanna, S1
Zara, I1
Pitzalis, M1
Zoledziewska, M1
Cucca, F1
Marini, F1
Comi, GP1
Scarpini, E1
Bresolin, N1
Clerici, M1
Sironi, M1

Other Studies

1 other study available for acebutolol and Genetic Predisposition

ArticleYear
A trans-specific polymorphism in ZC3HAV1 is maintained by long-standing balancing selection and may confer susceptibility to multiple sclerosis.
    Molecular biology and evolution, 2012, Volume: 29, Issue:6

    Topics: Acebutolol; Animals; Case-Control Studies; Gene-Environment Interaction; Genetic Association Studies

2012